Literature DB >> 21172194

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis.

E F Stange, S P L Travis, S Vermeire, W Reinisch, K Geboes, A Barakauskiene, R Feakins, J F Fléjou, H Herfarth, D W Hommes, L Kupcinskas, P L Lakatos, G J Mantzaris, S Schreiber, V Villanacci, B F Warren.   

Abstract

Entities:  

Year:  2008        PMID： 21172194     DOI： 10.1016/j.crohns.2007.11.001

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  120 in total

1.  Association between red cell distribution width and disease activity in patients with inflammatory bowel disease.

Authors:  Chang Seok Song; Dong Il Park; Min Yong Yoon; Hyo Sun Seok; Jung Ho Park; Hong Joo Kim; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

Review 2.  MMX® Mesalazine: a review of its use in the management of mild to moderate ulcerative colitis.

Authors:  Lily P H Yang; Paul L McCormack
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

3.  Clinical presentation and treatment strategies for ulcerative colitis: A retrospective study of 247 inpatients.

Authors:  Yan-Cheng Dai; Ya-Li Zhang; Li-Juan Wang; Qian Guo; Kun Yang; Ren-Hao Ye; Zhi-Peng Tang
Journal:  Chin J Integr Med       Date:  2015-10-26       Impact factor: 1.978

Review 4.  The diagnosis and treatment of Crohn's disease and ulcerative colitis.

Authors:  Daniel C Baumgart
Journal:  Dtsch Arztebl Int       Date:  2009-02-20       Impact factor: 5.594

5.  Going Third Class: Treatment of Steroid-Dependent Ulcerative Colitis.

Authors:  Helen Lee; Yecheskel Schneider; Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2019-05       Impact factor: 3.199

6.  Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.

Authors:  Iris Dotan; Etgar Levy-Nissenbaum; Yehuda Chowers; Alexander Fich; Eran Israeli; Tomer Adar; Shimon Shteingart; Hermona Soreq; Eran Goldin
Journal:  Dig Dis Sci       Date:  2016-08-29       Impact factor: 3.199

7.  Steroids and 5-aminosalicylic acids in moderate ulcerative colitis: addressing the dilemma.

Authors:  Chris Probert
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

Review 8.  Current role of capsule endoscopy in Crohn's disease.

Authors:  Marisol Luján-Sanchis; Laura Sanchis-Artero; Laura Larrey-Ruiz; Laura Peño-Muñoz; Paola Núñez-Martínez; Génesis Castillo-López; Lara González-González; Carlos Boix Clemente; Cecilia Albert Antequera; Ana Durá-Ayet; Javier Sempere-Garcia-Argüelles
Journal:  World J Gastrointest Endosc       Date:  2016-09-16

9.  Usefulness of salicylate and thiopurine coprescription in steroid-dependent ulcerative colitis and withdrawal strategies.

Authors:  Fernando Bermejo; Javier P Gisbert
Journal:  Ther Adv Chronic Dis       Date:  2010-05       Impact factor: 5.091

10.  The GRADE approach for assessing new technologies as applied to apheresis devices in ulcerative colitis.

Authors:  Nora Ibargoyen-Roteta; Iñaki Gutiérrez-Ibarluzea; Rosa Rico-Iturrioz; Marta López-Argumedo; Eva Reviriego-Rodrigo; Jose Luis Cabriada-Nuño; Holger J Schünemann
Journal:  Implement Sci       Date:  2010-06-16       Impact factor: 7.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.